TISSUE ENGINEERING OF THE ORAL MUCOSA



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This review contains the systematized data on the development and application of tissue engineering methods to generate in vitro oral mucosa (OM) tissues and its full-thickness equivalents. The data are presented describing the cultivation of epithelial mono-layers and stratified sheets and connective tissue component, as well as their unification into the tissue-engineered constructs reproducing the structure of native OM. The equivalents engineered in vitro are used as the transplants in the areas of the defects of OM, or of some other mucous membranes and the skin. They are also widely applied as test-systems for in vitro experiments conducted to assess the effect of various factors on OM.

About the authors

V L Bykov

V L Bykov

References

  1. Быков В.Л. Функциональная морфология эпителиального барьера слизистой оболочки полости рта. Стоматология, 1997, № 2, с. 15-20.
  2. Быков В.Л. Дендритные антигенпредставляющие клетки слизистой оболочки полости рта в норме и при патологических состояниях. Арх. пат., 1997, т. 59, № 2, с. 71-75.
  3. Быков В.Л. Иммунокомпетентные клетки десны человека в норме и при воспалительных заболеваниях пародонта. Арх. пат., 2005, т. 67, № 2, с. 51-55.
  4. Быков В.Л. Гистология и эмбриология органов полости рта человека. СПб., СОТИС, 2008.
  5. Васильев А.В., Воротеляк Е.А., Киселев И.В. и Терских В.В. Реконструкция эпителиальных тканей с использованием клеточных технологий. Вестн. РАМН., 2008, № 2, с. 45-53.
  6. Гемонов В.В., Лаврова Э.Н. и Фалин Л.И. Развитие и строение органов ротовой полости и зубов. М, изд. ВУНМЦ МЗ РФ, 2002.
  7. Alaminos M., Garzon I., Sanchez-Quevedo M.C. et al. Timecourse study of histological and genetic patterns of differentiation in human engineered oral mucosa. J. Tissue Eng. Regen. Med., 2007, v. 1, № 5, p. 350-359.
  8. Alsberg E., Hill E.E. and Mooney D.J. Craniofacuial tissue engineering. Crit. Rev. Oral Biol. Med., 2001, 12, № 1, p. 64-75.
  9. Andrian E., Grenier D. and Rouabhia M. In vitro models of tissue penetration and destruction by Porphyromonas gingivalis. Infect. Immun., 2004, v.72, p. 4689-4698.
  10. Andrian E., Mostefaoui Y., Rouabhia M. and Grenier D. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model. J. Cell Physiol., 2007, v. 211, № 1, p. 56-62.
  11. Arenholt-Bindslev D., Jepsen A., MacCallum D.K. and Lillie J.H. The growth and structure of human oral keratinocytes in culture. J. Invest. Dermatol., 1987, v.88, p. 314-319.
  12. Baum B.J. and Mooney D.J. The impact of tissue engineering on dentistry. JADA, 2000, v. 131, p. 309-318.
  13. Bhargava S., Chapple C.R., Bullock A.J. et al. Tissue-engineered buccal mucosa for substitution urethroplasty. BJU Int., 2004, v. 93, p. 807-811.
  14. Bhargava S., Patterson J.M., Inman R.D. et al. Tissueengineered buccal mucosa urethroplasty-clinical outcomes. Eur. Urol., 2008, v. 53, № 6, p. 1263-1269.
  15. Bodner L. and Grossman N. Autologous cultured mucosal graft to cover large intraoral mucosal defects: a clinical study. J. Oral Maxillofac. Surg., 2003, v. 61, p. 169-173.
  16. Bussi M., Valente G., Curato M.P. et al. Is transposed skin transformed in major head and neck mucosal reconstruction? Acta Otolaryngol., 1995, v. 115, № 2, p. 348-351.
  17. Ceder R., Merne M., Staab C.A. et al.The application of normal, SV40 T-antigen-immortalised and tumour-derived oral keratinocytes, under serum-free conditions, to the study of the probability of cancer progression as a result of environmental exposure to chemicals. Altern. Lab. Anim., 2007, v. 35, № 6, p. 621-639.
  18. Chang S.E., Foster S., Betts D. and Marnock W.E. DOK, a cell line established from human dysplastic oral mucosa, shows a partially transformed non-malignant phenotype. Int. J. Cancer, 1992, v. 52, № 6, p. 896-902.
  19. Chen C.M., Yang C.F., Huang I.Y. et al. Clinical evaluation of a new bilayer artificial dermis for repair of oral mucosal defects: report of two cases. Kaohsiung J. Med. Sci., 2004, v. 20, № 10, p. 516-520.
  20. Chinnathambi S., Tomanek-Chalkley A., Ludwig N. et al. Recapitulation of oral mucosal tissues in long-term organotypic culture. Anat. Rec. A Discov. Mol. Cell Evol. Biol., 2003, v. 270 , № 2, p. 162-74.
  21. Cho K.H., Ahn H.T., Park K.C. et al. Reconstruction of human hard-palate mucosal epithelium on de-epidermized dermis. J. Dermatol. Sci., 2000, v. 22, p. 117-124.
  22. Clugston P.A., Snelling C.F., Macdonald I.B. et al. Cultured epithelial autografts: three years of clinical experience with eighteen patients. J. Burn Care Rehabil., 1991, v. 12, p. 533-539.
  23. Costea D.E., Johannessen A.C. and Vintermyr O.K. Fibroblast control on epithelial differentiaion is gradually lost during in vitro tumor progression. Differentiation, 2005, v. 73, № 4, p. 134-141.
  24. De Luca M., Albanese E., Megna M. et al. Evidence that human oral epithelium reconstituted in vitro and transplanted onto patients with defects in the oral mucosa retains properties of the original donor site. Transplantation, 1990, v. 50, p. 454-459.
  25. Dongari-Bagtzoglou A. and Kashleva H. Development of a highly reproducible three-dimensional organotypic model of the oral mucosa. Nat. Protoc., 2006, v. 1, № 4, p. 2012-2018.
  26. Dongari-Bagtzoglou A.I. and Kashleva H. Development of a novel three-dimensional in vitro model of oral Candida infection. Microb. Pathogen., 2006, v. 40, № 6, p. 271-278.
  27. Feinberg S.E. and Izumi K. Tissue engineering of a human oral mucosa for tissue repair and regeneration. Oral. Biosci. Med., 2005, v. 2, № 2/3, p. 147-151.
  28. Fundamentals of Tissue Engineering and Regenerative Medicine. Berlin, Heidelberg, Springer-Verlag, 2009.
  29. Gaballah K., Costea D.E., Hills A. et al. Tissue engineering of oral dysplasia. J. Pathol., 2008, v. 215, № 3, p. 280-289.
  30. Garzon I., Sanchez-Quevedo M.C., Moreu G. et al. In vitro and in vivo cytokeratin patterns of expression in bioengineered human periodontal mucosa. J. Periodontal Res., 2009, v. 144, p. 588-597.
  31. Gilchrist E.P., Moyer M.P., Shillitoe E.J. et al. Establishment of a human polyclonal oral epithelial cell line. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2000, v. 90, № 3, p. 340-347.
  32. Grossman N. and Bodner L. Application of banked autologous mucosal cells to graft large intraoral mucosal defects. Cell Tissue Bank., 2001, v. 2, № 4, p. 241-247.
  33. Han Y.W., Ikegami A., Rajanna C. et al. Identification of a novel adhesin unique to oral fusobacteria. J. Bacteriol., 2005, v. 187, № 15, p. 5330-5340.
  34. Hansson A., Bloor B.K., Sarang Z. et al. Analysis of proliferation, apoptosis and keratin expression in cultured normal and immortalized human buccal keratinocytes. Eur. J. Oral. Sci., 2003, v. 111, № 1, p. 34-41.
  35. Hata K., Kagami H., Ueda M. et al. The characteristics of cultured mucosal cell sheet as a material for grafting; comparison with cultured epidermal cell sheet. Ann. Plast. Surg., 1995, v. 34, p. 530-538.
  36. Hayashida Y., Nishida K., Yamato M. et al. Ocular surface reconstruction using autologous rabbit oral mucosal epithelial sheets fabricated ex vivo on a temperature-responsive culture surface. Invest. Ophthalmol. Vis. Sci., 2005, v. 46, № 5, p. 1632-1639.
  37. Hearnden V., Lomas H., Macneil S. et al. Diffusion studies of nanometer polymersomes across tissue engineered human oral mucosa. Pharm. Res., 2009, v. 26, № 7, p. 1718-1728.
  38. Hernandez R. and Rupp S. Human epithelial model systems for the study of Candida infections in vitro: part II. Histologic methods for studying fungal invasion. Methods Mol. Biol., 2009, v. 470, p. 105-123.
  39. Higa K. and Shimazaki J. Recent advances in cultivated epithelial transplantation. Cornea, 2008, v. 27, Suppl. 1, p. S41-S47.
  40. Hillerup S. Grafting of skin and oral mucosa in the oral and maxillofacial regions. In: Oral and Maxillofacial Clinics of North America. Philadelphia, Saunders, 1993, v. 5, p. 557-577.
  41. Hotta T., Yokoo S., Terashi H. and Komori T. Clinical and histopathological analysis of healing process of intraoral reconstruction with ex vivo produced oral mucosa equivalent. Kobe J. Med. Sci., 2007, v. 53, № 1, p. 1-14.
  42. Iida T., Takami Y., Yamaguchi R. et al. Development of a tissueengineered human oral mucosa equivalent based on an acellular allogeneic dermal matrix: a preliminary report of clinical application to burn wounds. Scand. J. Plast. Reconstr. Surg. Hand Surg., 2005, v. 39, p. 138-146.
  43. Inatomi T., Nakamura T., Koizumi N. et al. Midterm results on ocular surface reconstruction using cultivated autologous oral mucosal epithelial transplantation. Am. J. Ophthalmol., 2006, v. 141, № 2, p. 267-275.
  44. Izumi K., Feinberg S.E., Iida A. and Yoshizawa M. Intraoral grafting of an ex vivo produced oral mucosa equivalent: a preliminary report. Int. J. Oral. Maxillofac. Surg., 2003, v. 32, p. 188-197.
  45. Izumi K., Feinberg S.E., Terashi H. and Marcelo C.L. Evaluation of transplanted tissue-engineered oral mucosa equivalents in severe combined immunodeficient mice. Tissue Eng., 2003, v. 9, p. 163-174.
  46. Izumi K., Song J. and Feinberg S.E. Development of a tissueengineered human oral mucosa: from the bench to the bedside. Cells Tissues Organs, 2004, v. 176, p. 134-152. 69 Том 137. № 1 ОБЗОРЫ
  47. Izumi K., Takacs G., Terashi H. and Feinberg S.E. Ex vivo development of a composite human oral mucosal equivalent. J. Oral Maxillofac. Surg., 1999, v. 57, p. 571-577.
  48. Izumi K., Terashi H., Marcelo C.L. and Feinberg S.E. Development and characterization of a tissue-engineered human oral mucosal equivalent produced in a serum-free culture system. J. Dent. Res., 2000, v. 79, p. 798-805.
  49. Izumi K., Tobita T. and Feinberg S.E. Isolation of human oral keratinocyte progenitor/stem cells. J. Dent. Res., 2007, v. 86, № 4, p. 341-346.
  50. Jacobsen J., Nielsen E.B., Brondum-Nielsen K. et al. Filtergrown TR146 cells as an in vitro model of human buccal epithelial permeability. Eur. J. Oral Sci., 1999, v. 107, № 2, p. 138-146.
  51. Ji S., Shin J.E., Kim Y.S. et al. Toll-like receptor 2 and NALP2 mediate induction of human beta-defensins by fusobacterium nucleatum in gingival epithelial cells. Infect Immun., 2009, v. 77, № 3, p. 1044-1052.
  52. Kimball J., Nittayananta W., Klausner M. et al. Antimicrobial barrier of an in vitro oral epithelial level. Arch. Oral Biol., 2006, v. 51, p. 775-783.
  53. Klausner M., Ayehunie S., Breyfogle B.A. et al. Organotypic human oral tissue models for toxicological studies. Toxicol. in Vitro, 2007, v. 21, p. 938-949.]
  54. Lauer G. Autografting of feeder-cell free cultured gingival epithelium. Method and clinical application. J. Craniomaxillofac. Surg., 1994, v. 22, p. 18-22.
  55. Lauer G. Discussion: Use of cultured mucosal grafts to cover defects caused by vestibuloplasty. An in vitro study. J. Oral Maxillofac. Surg., 1995, v. 53, p. 878-879.
  56. Lauer G. Mucosa tissue engineering. In: Fundamentals of Tissue Engineering and Regenerative Medicine. Berlin, Heidelberg, Springer-Verlag, 2009, p. 369-380.
  57. Lauer G., Otten J.E., von Specht B.U. and Schilli W. Cultured gingival epithelium. A possible suitable material for pre-prosthetic surgery. J. Craniomaxillofac. Surg., 1991, v. 19, p. 21-26.
  58. Lauer G. and Schimming R. Tissue-engineered mucosa graft for reconstruction of the intraoral lining after freeing of the tongue: a clinical and immunohistologic study. J. Oral Maxillofac. Surg., 2001, v. 59, p. 169-175.
  59. Lauer G. und Schimming R. Klinische Anwendung von im Tissue engineering gewonnen autologen Mundschleimhauttrasplantaten. Mund Kiefer Gesichtschir., 2002, Bd. 6, № 6, S. 379-393.
  60. Lauer G., Schimming R. and Frankenschmidt A. Intraoral wound closure with tissue-engineered mucosa: new perspectives for urethra reconstruction with buccal mucosa grafts. Plast. Reconstr. Surg., 2001, v. 107, № 1, p. 25-33.
  61. Li C., Xu Y.M., Song L.J. et al. Urethral reconstruction using oral keratinocyte seeded bladder acellular matrix grafts. J. Urol., 2008, v. 180, № 4, p. 1538-1542.
  62. Li H., Zhang D., Wen Y. and Wang C. Growth of compound layer tissue engineered oral mucosa and its clinical application in hetero-transplantation. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2006, v. 20, № 2, p. 177-180.
  63. Locke M., Hyland P.L., Irwin C.R. and Mackenzie I.C. Modulation of gingival epithelial phenotypes by interactions with regionally defined populations of fibroblasts. J Periodontal Res., 2008, v. 43, № 3, p. 279-289.
  64. Marler J.J., Upton J., Langer R. and Vacanti J.P. Transplantation of cells in matrices for tissue regeneration. Adv. Drug Del. Rev., 1998, v. 33, p. 165-182.
  65. Masuda I. An in vitro oral mucosal model reconstructed from human normal gingival cells. Kokubyo Gakkai Zasshi, 1996, v. 63, p. 334-353.
  66. Merne M. and Syrjanen S. The mesenchymal substrate influences the epithelial phenotype in a three-dimensional cell culture. Arch. Dermatol. Res., 2003, v. 295, p. 190-198.
  67. Moharamzadeh K., Brook I.M., Van Noort R. et al. Tissueengineered oral mucosa: a review of the scientific literature. J. Dent. Res., 2007, v. 86, № 2, p. 115-124.
  68. Moharamzadeh K., Brook I.M., Van Noort R. et al. Development, optimization and characterization of a full-thickness tissue engineered human oral mucosal model for biological assessment of dental biomaterials. J. Mater. Sci. Mater. Med., 2008, v. 19, № 4, p. 1793-1801.
  69. Moriyama T., Asahina I., Ishii M. et al. Development of composite cultured oral mucosa utilizing collagen sponge matrix and contracted collagen gel: a preliminary study for clinical applications. Tissue Eng., 2001, v. 7, p. 415-427.
  70. Mostefaoui Y., Claveau I., Ross G. and Rouabhia M. Tissue structure, and IL-1beta, IL-8, and TNF-alpha secretions after contact by engineered human oral mucosa with dentifrices. J. Clin. Periodontol., 2002, v. 29, p. 1035-1041.
  71. Munoz A.C. Ingenieria tisular de la mucosa bucal. An. R. Acad. Nac. Med. (Madr). 2007, v. 124, № 1, p. 157-165.
  72. Murata M., Momose M., Okuda K. et al. Immunohistochemical localization of cytokeratin 19, involucrin and proliferating cell nuclear antigen (PCNA) in cultured human gingival epithelial sheets. J. Int. Acad. Periodontol., 2006, v. 8, № 1, p. 33-38.
  73. Navarro F.A., Mizuno S., Huertas J.C. et al. Perfusion of medium improves growth of human oral neomucosal tissue constructs. Wound Repair Regen., 2001, v. 9, p. 507-512.
  74. Nishida K., Yamato M., Hayashida Y. et al. Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N. Engl. J. Med., 2004, v. 351, № 12, p. 1187-1196.
  75. Oda D. and Watson E. Human oral epithelial cell culture I. Improved conditions for reproducible culture in serum-free medium. In Vitro Cell. Dev. Biol., 1990, v. 26, p. 589-595.
  76. Ohki T., Yamato M., Murakami D. et al. Treatment of oesophageal ulcerations using endoscopic transplantation of tissueengineered autologous oral mucosal epithelial cell sheets in a canine model. Gut, 2006, v. 55, № 12, p. 1704-1710.
  77. Okuda K., Momose M., Murata M. et al. Treatment of chronic desquamative gingivitis using tissue-engineered human cultured gingival epithelial sheets: a case report. Int. J. Periodontics Restorative Dent., 2004, v. 24, № 2, p. 119-125.
  78. Ophof R., van Rheden R.E., Von den Hoffa J.W. et al. Oral keratinocytes cultured on dermal matrices form a mucosa-like tissue. Biomaterials, 2002, v. 23, p. 3741-3748.
  79. Pomahac B., Svensjo T., Yao H. et al. Tissue engineering of skin. Crit. Rev. Oral Biol. Med., 1998, v. 9, № 3, p. 333-344.
  80. Raghoebar G.M., Tompson A.M., Schloma J. et al. Use of cultured mucosal grafts to cover defects caused by vestibuloplasty. An in vitro study. J. Oral. Maxillofac. Surg., 1995, v. 53, p. 872-878.
  81. Rassing M.R. and Nielsen H.M. Nicotine permeability across the buccal TR146 cell culture model and porcine buccal mucosa in vitro: effect of pH and concentration. Eur. J. Pharm. Sci., 2002, v. 16, № 3, p. 151-157.
  82. Rhee P.H., Friedman C.D., Ridge J.A. and Kusiak J. The use of processed allograft dermal matrix for intraoral resurfacing: an alternative to split-thickness skin grafts. Arch. Otolaryngol. Head Neck Surg., 1998, v. 124, № 11, p. 1201-1204.
  83. Rouabhia M. and Deslauriers N. Production and characterization of an in vitro engineered human oral mucosa. Biochem. Cell Biol., 2002, v. 80, № 2, p. 189-195.
  84. Sanchez-Quevedo M.C., Alaminos M., Capitan L.M. et al. Histological and histochemical evaluation of human oral mucosa constructs developed by tissue engineering. Histol. Histopathol., 2007, v. 22, № 6, p. 631-640.
  85. Sauerbier S., Gutwald R., Wiedmann-Al-Ahmad M. et al. Clinical application of tissue-engineered transplants. Part I: mucosa. Clin. Oral Implants Res., 2006, v. 17, № 6, p. 625-632.
  86. Schaller M. Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia for the study of host-pathogen interactions. Methods Mol. Biol., 2009, v. 470, p. 327-345.
  87. Scheller E.L., Krebsbach P.H. and Kohn D.H. Tissue engineering: state of the art in oral rehabilitation. J. Oral Rehabil., 2009, v. 36 , № 5, p. 368-389.
  88. Schliephake H. Tisue engineering in maxillofacial surgery. In: Fundamentals of Tissue Engineering and Regenerative Medicine. Berlin, Heidelberg, Springer-Verlag, 2009, p. 827- 834.
  89. Schmalz G., Arenholt-Bindslev D., Hiller K.A. and Schweikl H. Epithelium-fibroblast co-culture for assessing mucosal irritancy of metals used in dentistry. Eur. J. Oral Sci., 1997, v. 105, p. 86-91.
  90. Schmalz G., Schweikl H. and Hiller K.A. Release of prostaglandin E2, IL-6 and IL-8 from human oral epithelial culture models after exposure to compounds of dental materials. Eur. J. Oral Sci.,2000, v. 108, № 5, p. 442-448.
  91. Sekiyama E., Nakamura T., Kawasaki S. et al. Different expression of angiogenesis-related factors between human cultivated corneal and oral epithelial sheets. Exp Eye Res., 2006, v. 83, № 4, p. 741-746.
  92. Squier C.A. and Finkelstein M.W. Oral mucosa. In: Ten Cate's Oral Histology/ Ed. Nanci A. 7th Edition. Orlando, FL, Mosby Inc., 2007, p. 319-357.
  93. Staab C.A., Vondracek M., Custodio H. et al. Modelling of normal and premalignant oral tissue by using the immortalised cell line, SVpgC2a: a review of the value of the model. Altern. Lab. Anim., 2004, v. 32, № 4, p. 401-405.
  94. Taichman L.B. In vitro cultivation of human oral keratinocytes. Arch. Oral Biol., 1979, v. 24, № 5, p. 335-341.
  95. Tsai C., Ueda M., Hata K. et al. Clinical results of cultured epithelial cell grafting in the oral and maxillofacial region. J. Craniomaxillofac. Surg., 1997, v. 25, p. 4-8.
  96. Ueda M., Ebata K. and Kaneda T. In vitro fabrication of bioartificial mucosa for reconstruction of oral mucosa: basic research and clinical application. Ann. Plast. Surg., 1991, v. 27, p. 540-549.
  97. Ueda M., Hata K., Horie K. and Torii S. The potential of oral mucosal cells for cultured epithelium: a preliminary report. Ann. Plast. Surg., 1995, v. 35, p. 498-504.
  98. Ueda M., Tohnai I. and Nakai H. Tissue engineering research in oral implant surgery. Artif. Organs, 2001, v. 25, № 3, p. 164- 171.
  99. Uitto V.J., Baillie D., Wu Q. et al. Fusobacterium nucleatum increases collagenase 3 production and migration of epithelial cells. Infect. Immun., 2005, v. 73, № 2, p. 1171-1179.
  100. Vacanti J.P. and Langer R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet, 1999, v. 354 (Suppl. 1), p. S132-S134.
  101. Wagshall E., Lewis Z., Babich S.B. et al. Acellular dermal matrix allograft in the treatment of mucogingival defects in children: illustrative case report. ASDC J. Dent. Child, 2002, v. 69, p. 39-43.
  102. Wang Y., Liu L., Li Y. et al. Biocompatibility of acellular urinary bladder submucosa. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 2006, v. 20, № 3, p. 210-212.
  103. Wei P.C., Laurell L., Lingen M.W. and Geivelis M. Acellular dermal matrix allogrfts to achieve increased attached gingiva. Part 2. A histological comparative study. J. Periodontol., 2002, v. 73, № 3, p. 257-265.
  104. Xiong X., Zhao Y., Zhang W. et al. In vitro engineering of a palatal mucosa equivalent with acellular porcine dermal matrix. J. Biomed. Mater. Res., A. 2008, v. 86, № 2, p. 544-551.
  105. Yoshizawa M., Feinberg S.E., Marcelo C.L. and Elner V.M. Ex vivo produced human conjunctiva and oral mucosa equivalents grown in a serum-free culture system. J. Oral Maxillofac. Surg., 2004, v. 62, p. 980-988.
  106. Zhang W., Hu M., Wang E.B. and Bu J.Q. The ckinical application of acellular dermal matrix to repair the defect of oral mucosa. Zhonghua Kou Qiang Yi Xue Za Zhi, 2005, v. 40, № 3, p. 241-243.
  107. Zhou Z., Zhou H., Shang Q. and Cao Y. In-vitro cultivation of normal human oral keratinocytes. Chin. Med. J. (Engl), 2001, v. 114, № 7, p. 731-734.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 0110212 от 08.02.1993.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies